Skip to main content

Table 2 FDA-approved nanodrugs in the market

From: Nanotechnology advances towards development of targeted-treatment for obesity

Nanodrug tradename Nanocarrier Drug Application Company
Abraxane Albumin NPs Paclitaxel Breast cancer, metastatic pancreatic cancer, non-small cell lung cancer Celgene
Albelcet Liposomes Amphotericin B Fungal infection Sigma-Tau
Curosurf Poractant alfa Respiratory distress syndrome Chiesi USA
Doxil Doxorubicin Karposiā€™s sarcoma, ovarian cancer, multiple myeloma Janssen
DepoDur Morphine sulphate Postoperative analgesia Pacira Pharmaceuticals
Marqibo Vincristine sulfate Acute lymphoid leukemia Talon Therapeutics
Thermodox Doxorubicin Hepatobiliary tumors Celsion corp
Copaxone Polymeric NPs Glatiramer acetate Multiple sclerosis Teva Pharmaceuticals
Neulasta Pegfilgrastim Neutropenia Amgen
Paclical Micelle NPS Paclitaxel Ovarian cancer Oasmia Pharmaceutical
Rapamune Nanocrystals Sirolimus Lymphangioleiomyomatosis and an immunosuppressants Elan Nanosystems (now Alkermes)
Emend Aprepitant Prevent nausea and vomiting after surgery or chemotherapy Merck
Tricor Fenofibrate Reduces cholesterol and TAGs AbbVie
Feraheme Inorganic NPs Ferumoxytol Anemia associated with chronic kidney disease AMAG Pharmaceuticals